+8615710194249

News Center

Why is CDMO a "new drug copier"?

2024-01-29

CDMO(Contract Development and Manufacturing Organization) is a third-party organization that undertakes drug development and production. Why is CDMO called a "new drug copier?

First of all, CDMO has the highly specialized strength and rich experience to provide the best services from drug development to production. This means that pharmaceutical companies only need to provide innovative drug research and development programs without worrying about the production process, which greatly shortens the time for new drugs to go on the market. It can be said that CDMO is like a "copier" that quickly replicates new drugs, transforming the research and development process of innovative drugs into an industrial production process.

Secondly, CDMO adopts advanced production technology and equipment to ensure drug quality and stability. This is necessary for the launch of new drugs because it is difficult to fully control quality and production efficiency during drug development. CDMO can reduce costs, improve efficiency, and ensure the quality and production capacity of new drugs through large-scale production.

Finally, CDMO can also provide flexible cooperation to meet the different needs of pharmaceutical companies. Whether it is fully managed R & D and production, or partially commissioned cooperation, CDMO can provide personalized services according to the requirements of pharmaceutical companies. This saves a lot of time and resources for pharmaceutical companies and increases the chances of successful listing.

In summary, CDMO, as a "new drug copier", has the best service capabilities, advanced technology and equipment, and flexible cooperation methods, providing pharmaceutical companies with fast and high-quality drug research and development and production services, and accelerating the development of new drugs. Listing process.